Impaired function of lecithin:cholesterol acyltransferase in atherosclerosis-susceptible White carneau pigeons: Possible effects on metabolism of oxidized phospholipids

Journal of Lipid Research

Volumn 39, Issue 2, 1998, Pages 245-254

  Liu, Ming ^a   St Clair, Richard W ^b   Subbaiah, Papasani V ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Free cholesterol PC ratio; LGAT; Lysophospholipids; PAF acetylhydrolase

Indexed keywords

CHOLESTEROL ESTER; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; ESTERIFICATION; HYDROLYSIS; LIPID OXIDATION; LIPOPROTEIN METABOLISM; NONHUMAN; PHOSPHOLIPID METABOLISM; PIGEON; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; CHOLESTEROL; CHOLESTEROL ESTERS; COLUMBIDAE; ESTERIFICATION; FEMALE; HYDROLYSIS; MALE; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; RISK FACTORS;

EID: 0031888034     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Glomset, J. A. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid. Res. 9: 155-167.
2. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. Review. J. Lipid. Res. 36: 211-228.
3. Subbaiah, P. V., J. J. Albers, C. H. Chen, and J. D. Bagdade. 1980. Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin:cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin:cholesterol acyltransferase. J. Biol. Chem. 255: 9275-9280.
4. Liu, M., and P. V. Subbaiah. 1994. Hydrolysis and transesterification of platelet-activating factor by lecithin:cholesterol acyltransferase. Proc. Natl. Acad. Sci. USA. 91: 6035-6039.
5. Goyal, J., K. Wang, M. Liu, and P. V. Subbaiah. 1997. Novel function of lecithin:cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation. J. Biol. Chem. 272: 16231-16239.
6. Stafforini, D. M., S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1996. Mammalian platelet-activating factor acetylhydrolases. Biochim. Biophys. Acta. 1301: 161-173.
7. Cabot, M. C., L. A. Faulkner, R. J. Lackey, and F. Snyder. 1984. Vertebrate class distribution of 1-alkenyl-2-acetyl-snglycerophosphocholine acetylhydrolase in serum. Comp. Biochem. Physiol. 78B: 37-40.
8. Watson, A. D., J. A. Berliner, S. Y. Hama, B. N. Ladu, K. F. Faull, A. M. Fogelman, and M. Navab. 1995. Protective effect of high density lipoprotein associated paraoxonase-inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96: 2882-2891.
9. Mackness, M. I. 1989. 'A'-esterases. Enzymes looking for a role? Biochem. Pharmacol. 38: 385-390.
10. Wagner, W. D., T. B. Clarkson, M. A. Feldner, and R. W. Prichard. 1973. The development of pigeon strains with selected atherosclerosis characteristics. Exp. Mol. Pathol. 19: 307-319.
11. Barakat, H. A., and R. W. St. Clair. 1985. Characterization of plasma lipoproteins of grain- and cholesterol-fed White Carneau and Show Racer pigeons. J. Lipid. Res. 26: 1252-1268.
12. Young, F., and C. C. Middleton. 1966. Correlation of arachidonic acid of sterol esters with restrictive and susceptibility to naturally occurring atherosclerosis in pigeons. Proc. Soc. Exp. Biol. Med. 123: 816-819.
13. Yancey, P. G., and R. W. St. Clair. 1992. Cholesterol efflux is defective in macrophages from atherosclerosis-susceptible White Carneau pigeons relative to resistant Show Racer pigeons. Arterioscler. Thromb. 12: 1291-1304.
14. Yancey, P. G., and R. W. St. Clair. 1994. Mechanism of the defect in cholesteryl ester clearance from macrophages of atherosclerosis-susceptible White Carneau pigeons. J. Lipid. Res. 35: 2114-2129.
15. 2 biosynthesis and effect in pigeon aorta. Possible role in atherogenesis. Atherosclerosis. 29: 487-495.
16. Hogg, S. I., and A. Cryer. 1983. A comparison of the lipoprotein lipase activity in the tissues and post-heparin plasma of atherosclerosis-susceptible and atherosclerosis-resistent pigeons. Comp. Biochem. Physiol. [B] 74: 593-596.
17. Solajic-Bozicevic, N., A. Stavljenic-Rukavina, and M. Sesto. 1994. Lecithin:cholesterol acyltransferase activity in patients with coronary artery disease examined by coronary angiography. Clin. Invest. 72: 951-956.
18. Ozerova, I. N., E. N. Gerasimova, F. T. Mai, and K. A. Kurdanov. 1984. Esterifying activity of the plasma in patients with ischemic heart disease. Vopr. Med. Khim. 30: 118-123.
19. Hoeg, J. M., S. Santamarina-Fojo, A. M. Berard, J. F. Cornhill, E. E. Herderick, S. H. Feldman, C. C. Haudenschild, B. L. Vaisman, R. F. Hoyt, S. J. Demosky, R. D. Kauffman, C. M. Hazel, S. M. Marcovina, and H. B. Brewer. 1996. Over-expression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad. Sci. USA. 93: 11448-11453.
20. Liu, M., J. D. Bagdade, and P. V. Subbaiah. 1995. Specificity of lecithin:cholesterol acyltransferase and atherogenic risk. Comparative studies on the plasma composition and in vitro synthesis of cholesteryl esters in 14 vertebrate species. J. Lipid. Res. 36: 1813-1824.
21. Kuksis, A., J. J. Myher, K. Geher, G. J. L. Jones, W. C. Breckenridge, T. Feather, D. Hewitt, and J. A. Little. 1982. Decreased plasma phosphatidylcholine/free cholesterol ratio as an indicator of risk for ischemic vascular disease. Arteriosclerosis. 2: 296-302.
22. Kuksis, A., A. Roberts, J. S. Thompson, J. J. Myher, and K. Geher. 1983. Plasma phosphatidylcholine/free cholesterol ratio as an indicator for atherosclerosis. Arteriosclerosis. 3: 389-397.
23. Stokke, K. T., and K. R. Norum. 1971. Determination of lecithin:cholesterol acyltransferase in human blood plasma. Scand. J. Clin. Lab. Invest. 27: 21-27.
24. Subbaiah, P. V., M. Liu, and T. R. Witt. 1997. Impaired cholesterol esterificatiori in the plasma in patients with breast cancer. Lipids. 32: 157-162.
25. Chen, C. H., and J. J. Albers. 1982. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity. J. Lipid. Res. 23: 680-691.
26. Subbaiah, P. V., and R. A. Rodby. 1994. Abnormal acyltransferase activities and accelerated cholesteryl ester transfer in patients with nephrotic syndrome. Metabolism. 24: 1126-1133.
27. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
28. Subbaiah, P. V., and M. Liu. 1996. Disparate effects of oxidation on plasma acyltransferase activities: inhibition of cholesterol esterification but stimulation of transesterification of oxidised phospholipids. Biochim. Biophys. Acta. 1301: 115-126.
29. Marinetti, G. V. 1962. Chromatographic separation, identification, and analysis of phosphatides. J. Lipid. Res. 3: 1-20.
30. Subbaiah, P. V., D. Kaufman, and J. D. Bagdade. 1993. Incorporation of dietary n-3 fatty acids into molecular species of phosphatidyl choline and cholesteryl ester in normal human plasma. Am. J. Clin. Nutr. 58: 360-368.
31. Goodman, D. S., D. Deykin, and T. Shiratori. 1964. The formation of cholesterol esters with rat liver enzymes. J. Biol. Chem. 239: 1335-1345.
32. Steinberg, D., S. Partbasarathy, T. E. Carew, J. C. Khoo, and J. L. Witzum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
33. Haberland, M. E., and U. P. Steinbrecher. 1992. Modified low-density lipoproteins: diversity and biological relevance in atherogenesis. Monogr. Hum. Genet. 24: 35-61.
34. Steinbrecher, U. P., S. Parthasarathy, D. S. Leake, J. L. Witztum, and D. Steinberg. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81: 3883-3887.
35. 2+ /ascorbate/EDTA-induced lipid peroxidation. Biochim. Biophys. Acta. 1166: 264-274.
36. Hengstschlager-Ottnad, E., K. Kuchler, and W. J. Schneider. 1995. Chicken lecithin:cholesterol acyltransferase. Molecular characterization reveals unusual structure and expression pattern. J. Biol. Chem. 270: 26139-26145.
37. Swell, L., H. Field, and C. R. Treadwell. 1960. Correlation of arachidonic acid of serum cholesterol esters in different species with susceptibility to atherosclerosis. Proc. Soc. Exp. Biol. Med. 104: 325-328.
38. Sugano, M., I. Chinen, and M. Wada. 1967. Rates of cholesterol esterification and turnover in vivo of individual cholesterol esters in the chicken plasma. J. Biochem. 61: 320-327.
39. Langelier, M., P. Connelly, and M. T. R. Subbiah. 1976. Plasma lipoprotein profile and composition in White Carneau and Show Racer breeds of pigeons, Can. J. Biochem. 54: 27-31.
40. Subbiah, M. T. R., and B. A. Dicke. 1976. On the cholesteryl ester hydrolase activity in the microsomal and super-natant fractions of pigeon aorta. Atherosclerosis. 24: 575-580.
41. Hoeg, J. M., B. L. Vaisman, S. J. Demosky, S. M. Meyn, G. D. Talley, R. F. Hoyt, S. Feldman, A. M. Berard, N. Sakai, D. Wood, M. E. Brousseau, S. Marcovina, H. B. Brewer, and S. Santamarina-Fojo. 1996. Lecithin:cholesterol acyltransferase overexpression generates hyperalphalipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits. J. Biol. Chem. 271: 4396-4402.
42. Fielding, C. J., and P. E. Fielding. 1981. Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin:cholesterol acyltransferase. Proc. Natl. Acad. Sci. USA. 78: 3911-3914.
43. Glomset, J. A., and K. R. Norum. 1973. The metabolic role of lecithin:cholesterol acyltransferase: perspectives from pathology. Adv. Lipid Res. 11: 1-65.
44. Frohlich, J., R. McLeod, P. H. Pritchard, J. Fesmire, and W. McConathy. 1988. Plasma lipoprotein abnormalities in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency. Metabolism. 37: 3-8.
45. Phillips, M. C., W. J. Johnson, and G. H. Rothhlat. 1987. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 906: 223-276.
46. Watson, A. D., M. Navab, S. Y. Hama, A. Sevanian, S. M. Prescott, D. M. Stafforini, T. M. McIntyre, B. N. Ladu, A. M. Fogelman, and J. A. Berliner. 1995. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95: 774-782.
47. Khan, B. V., S. S. Parthasarathy, R. W. Alexander, and R. M. Medford. 1995. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95: 1262-1270.
48. Portman, O. W., and D. R. Illingworth. 1973. Lysolecithin binding to human and squirrel monkey plasma and tissue components. Biochim. Biophys. Acta. 326: 34-42.
49. Quinn, M. T., N. Kondratenko, and S. Parthasarathy. 1991. Analysis of the monocyte chemotactic response to lysophosphatidylcholine: role of lysophospholipase C. Biochim. Biophys. Acta. 1082: 293-302.
50. Sugiyama, S., K. Kugiyama, M. Ohgushi, K. Fujimoto, and H. Yasue. 1994. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries: role of protein kinase C. Circ. Res. 74: 565-575.
51. Murohara, T., K. Kugiyama, M. Ohgushi, S. Sugiyama, Y. Ohta, and H. Yasue. 1994. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium-dependent relaxation. Am. J. Physiol. 36: H2441-H2449.